$1.17
2.18% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US67113Y1082
Symbol
NUWE

Nuwellis Inc Stock price

$1.17
-0.21 15.22% 1M
-3.07 72.42% 6M
-19.16 94.25% YTD
-19.66 94.38% 1Y
-4,128.83 99.97% 3Y
-88,303.83 100.00% 5Y
-3,616,199,998.83 100.00% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.03 2.18%
ISIN
US67113Y1082
Symbol
NUWE
Sector

Key metrics

Market capitalization $1.31m
Enterprise Value $0.00
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.00
EV/Sales (TTM) EV/Sales 0.00
P/S ratio (TTM) P/S ratio 0.15
P/B ratio (TTM) P/B ratio 0.69
Revenue growth (TTM) Revenue growth 3.66%
Revenue (TTM) Revenue $8.97m
EBIT (operating result TTM) EBIT $-12.19m
Free Cash Flow (TTM) Free Cash Flow $-10.84m
Cash position $1.91m
EPS (TTM) EPS $-116.60
P/E forward negative
P/S forward 0.15
EV/Sales forward 0.00
Short interest 17.27%
Show more

Is Nuwellis Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Nuwellis Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Nuwellis Inc forecast:

1x Buy
50%
1x Hold
50%

Analyst Opinions

2 Analysts have issued a Nuwellis Inc forecast:

Buy
50%
Hold
50%

Financial data from Nuwellis Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
8.97 8.97
4% 4%
100%
- Direct Costs 3.26 3.26
13% 13%
36%
5.71 5.71
16% 16%
64%
- Selling and Administrative Expenses 14 14
23% 23%
154%
- Research and Development Expense 3.75 3.75
29% 29%
42%
-12 -12
35% 35%
-132%
- Depreciation and Amortization 0.34 0.34
6% 6%
4%
EBIT (Operating Income) EBIT -12 -12
34% 34%
-136%
Net Profit -15 -15
8% 8%
-170%

In millions USD.

Don't miss a Thing! We will send you all news about Nuwellis Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nuwellis Inc Stock News

Neutral
GlobeNewsWire
10 days ago
MINNEAPOLIS, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (the “Company” or “Nuwellis”) today announced that the Company received formal written notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq's minimum bid price requirement (the “Bid Price Requirement”) set forth in Nasdaq Listing Rule 5550(a)(2), as well as Nasdaq's st...
Neutral
Seeking Alpha
about 2 months ago
Nuwellis, Inc. (NASDAQ:NUWE ) Q3 2024 Earnings Call Transcript November 11, 2024 9:00 AM ET Company Participants Vivian Cervantes - IR Nestor Jaramillo - President and CEO John Jefferies - CMO Rob Scott - CFO Conference Call Participants Jonathan Aschoff - Roth Anthony Vendetti - Maxim Group Operator Good day, everyone, and Welcome to Nuwellis' Third Quarter 2024 Earnings Conference Call. At th...
Neutral
GlobeNewsWire
about 2 months ago
MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with fluid overload, today reported financial results for the third quarter ended September 30, 2024.
More Nuwellis Inc News

Company Profile

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Head office United States
CEO Nestor Jaramillo
Employees 59
Founded 1999
Website www.nuwellis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today